SC Filed 2024-01-09 Event — SEC 0000921895-24-000070 →

BIOTECHNOLOGY VALUE FUND L P → Kymera Therapeutics, Inc. KYMR

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

54 transactions

0 buys · 52 sales · 2 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

40 filings by this filer

39 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 14.67

9,900,469 shares short · -2.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $13.47M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-06-25	Booth Bruce	director	Sale	37,179	$119.71	$4.45M
2026-06-25	Booth Bruce	director	Sale	112,299	$120.66	$13.55M
2026-06-25	Booth Bruce	director	Sale	40,774	$121.38	$4.95M
2026-06-25	Booth Bruce	director	Sale	4,977	$122.67	$611K
2026-06-25	Booth Bruce	director	Sale	10,860	$123.62	$1.34M
2026-06-25	Booth Bruce	director	Sale	11,711	$124.61	$1.46M
2026-06-25	Booth Bruce	director	Sale	3,716	$125.82	$468K
2026-06-25	Booth Bruce	director	Sale	1,609	$126.71	$204K
2026-06-25	Booth Bruce	director	Sale	25,075	$127.37	$3.19M
2026-06-25	Booth Bruce	director	Sale	2,197	$128.69	$283K
2026-06-25	Booth Bruce	director	Sale	337	$129.61	$44K
2026-06-25	Booth Bruce	director	Sale	5,144	$119.71	$616K
2026-06-25	Booth Bruce	director	Sale	15,660	$120.66	$1.89M
2026-06-25	Booth Bruce	director	Sale	5,689	$121.38	$691K
2026-06-25	Booth Bruce	director	Sale	698	$122.67	$86K
2026-06-25	Booth Bruce	director	Sale	1,517	$123.62	$188K
2026-06-25	Booth Bruce	director	Sale	1,639	$124.61	$204K
2026-06-25	Booth Bruce	director	Sale	522	$125.82	$66K
2026-06-25	Booth Bruce	director	Sale	223	$126.71	$28K
2026-06-25	Booth Bruce	director	Sale	3,507	$127.37	$447K
2026-06-25	Booth Bruce	director	Sale	305	$128.69	$39K
2026-06-25	Booth Bruce	director	Sale	46	$129.61	$6K
2026-06-25	Booth Bruce	director	Sale	9,994	$107.30	$1.07M
2026-06-25	Booth Bruce	director	Sale	159	$108.02	$17K
2026-06-25	Booth Bruce	director	Sale	14,351	$108.83	$1.56M

Showing 25 of 54

Other 13D/G Filings on Kymera Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-26	SCHEDULE 13D/A	BIOTECHNOLOGY VALUE FUND L P	6.30%	2,712,852	view →
2025-06-30	SCHEDULE	BAKER BROS. ADVISORS LP	9.50%	6,666,540	view →

Other Filings by BIOTECHNOLOGY VALUE FUND L P

Filed	Form	Issuer	Stake	Shares
2026-07-20	SCHEDULE 13G	Research Alliance Corp IV	—	—	view →
2026-07-16	SCHEDULE 13D/A	XOMA Royalty Corp	—	0	view →
2026-07-10	SCHEDULE 13G	Pyxis Oncology, Inc. PYXS	—	—	view →
2026-06-29	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	19.70%	8,302,735	view →
2026-06-26	SCHEDULE 13D/A	Kymera Therapeutics, Inc. KYMR	6.30%	2,712,852	view →
2026-06-04	SCHEDULE 13G	Q32 Bio Inc. QTTB	—	—	view →
2026-05-29	SCHEDULE 13G	Research Alliance Corp III RACC	—	—	view →
2026-05-27	SCHEDULE 13G	OnKure Therapeutics, Inc. OKUR	—	—	view →
2026-05-18	SCHEDULE 13D/A	XOMA Royalty Corp XOMAP	—	3,635,758	view →
2026-04-02	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	22.30%	8,302,735	view →
2025-11-24	SCHEDULE	Repare Therapeutics Inc.	24.00%	10,333,600	view →
2025-05-20	SCHEDULE	XOMA Royalty Corp XOMAP	21.60%	2,590,303	view →
2025-01-28	SCHEDULE	XOMA Royalty Corp XOMAP	25.30%	2,983,026	view →
2024-10-08	SC	MoonLake Immunotherapeutics MLTX	—	—	view →
2024-07-19	SC	Inventiva S.A. IVEVF	—	—	view →
2024-01-29	SC	Rain Oncology Inc.	—	—	view →
2023-12-18	SC	Rain Oncology Inc.	—	—	view →
2023-06-30	SC	MoonLake Immunotherapeutics MLTX	—	—	view →
2022-01-11	SC	Rain Therapeutics Inc.	—	—	view →
2021-09-15	SC	Rain Therapeutics Inc.	—	—	view →

Showing 20 of 39

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →